Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26.8M
-
Number of holders
-
85
-
Total 13F shares, excl. options
-
14.1M
-
Shares change
-
+949K
-
Total reported value, excl. options
-
$183M
-
Value change
-
+$12M
-
Put/Call ratio
-
0.54
-
Number of buys
-
54
-
Number of sells
-
-33
-
Price
-
$12.98
Significant Holders of Eton Pharmaceuticals, Inc. - Common Stock (ETON) as of Q1 2025
101 filings reported holding ETON - Eton Pharmaceuticals, Inc. - Common Stock as of Q1 2025.
Eton Pharmaceuticals, Inc. - Common Stock (ETON) has 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.1M shares
of 26.8M outstanding shares and own 52.6% of the company stock.
Largest 10 shareholders include Opaleye Management Inc. (2.85M shares), EcoR1 Capital, LLC (1.94M shares), Nantahala Capital Management, LLC (1.18M shares), VANGUARD GROUP INC (1.1M shares), CANNELL CAPITAL LLC (691K shares), Westside Investment Management, Inc. (494K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (449K shares), ACADIAN ASSET MANAGEMENT LLC (402K shares), MILLENNIUM MANAGEMENT LLC (356K shares), and BlackRock, Inc. (345K shares).
This table shows the top 85 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.